Coyright © 2019, Portalmascota.net
New product
Oral antitumor for the treatment of mast cell tumors in dogs.
This product is no longer in stock
Availability date:
The mast cell tumor is the most common malignant skin tumor in dogs, accounting for between 16-21% of skin tumors. Their behavior and progression is quite heterogeneous ranging from distinct slow-growing tumors with low potential for metastasis to very aggressive undifferentiated tumors with plenty of metastasis.
The Masitinib, Masivet® active principle, is an inhibitor of tyrosine kinase and potently inhibits c-kit receptor selectivael.
Presentation: 50 and 150 mg. Packs of 30 tablets
No customer reviews for the moment.
Coyright © 2019, Portalmascota.net
Follow us